Arcus Biosciences, Inc. (NYSE:RCUS) Receives Average Rating of “Moderate Buy” from Brokerages
Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) has received an average rating of “Moderate Buy” from the eight research firms that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price objective among […]
9 Mar 10:14 · The Markets Daily